149 related articles for article (PubMed ID: 27775082)
1. Functionalized magnetic nanowires for chemical and magneto-mechanical induction of cancer cell death.
Martínez-Banderas AI; Aires A; Teran FJ; Perez JE; Cadenas JF; Alsharif N; Ravasi T; Cortajarena AL; Kosel J
Sci Rep; 2016 Oct; 6():35786. PubMed ID: 27775082
[TBL] [Abstract][Full Text] [Related]
2. Biofunctionalization of Magnetic Nanomaterials.
Alsharif NA; Merzaban JS; Kosel J
J Vis Exp; 2020 Jul; (161):. PubMed ID: 32744515
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of doxorubicin-incorporated magnetic albumin nanospheres.
Zeybek A; Şanlı-Mohamed G; Ak G; Yılmaz H; Şanlıer ŞH
Chem Biol Drug Des; 2014 Jul; 84(1):108-15. PubMed ID: 24524300
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity and cellular uptake of iron nanowires.
Song MM; Song WJ; Bi H; Wang J; Wu WL; Sun J; Yu M
Biomaterials; 2010 Mar; 31(7):1509-17. PubMed ID: 19945156
[TBL] [Abstract][Full Text] [Related]
5. In vitro antiproliferative effects of albumin-doxorubicin conjugates against Ewing's sarcoma and peripheral neuroectodermal tumor cells.
Gabor F; Wollmann K; Theyer G; Haberl I; Hamilton G
Anticancer Res; 1994; 14(5A):1943-50. PubMed ID: 7847832
[TBL] [Abstract][Full Text] [Related]
6. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery.
Kossatz S; Grandke J; Couleaud P; Latorre A; Aires A; Crosbie-Staunton K; Ludwig R; Dähring H; Ettelt V; Lazaro-Carrillo A; Calero M; Sader M; Courty J; Volkov Y; Prina-Mello A; Villanueva A; Somoza Á; Cortajarena AL; Miranda R; Hilger I
Breast Cancer Res; 2015 May; 17(1):66. PubMed ID: 25968050
[TBL] [Abstract][Full Text] [Related]
7. A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting.
Gautier J; Munnier E; Paillard A; Hervé K; Douziech-Eyrolles L; Soucé M; Dubois P; Chourpa I
Int J Pharm; 2012 Feb; 423(1):16-25. PubMed ID: 21703340
[TBL] [Abstract][Full Text] [Related]
8. Magnetic hyperthermia and pH-responsive effective drug delivery to the sub-cellular level of human breast cancer cells by modified CoFe
Oh Y; Moorthy MS; Manivasagan P; Bharathiraja S; Oh J
Biochimie; 2017 Feb; 133():7-19. PubMed ID: 27916642
[TBL] [Abstract][Full Text] [Related]
9. Synergistic anti-cancer effects of grape seed extract and conventional cytotoxic agent doxorubicin against human breast carcinoma cells.
Sharma G; Tyagi AK; Singh RP; Chan DC; Agarwal R
Breast Cancer Res Treat; 2004 May; 85(1):1-12. PubMed ID: 15039593
[TBL] [Abstract][Full Text] [Related]
10. Functionalized magnetic dextran-spermine nanocarriers for targeted delivery of doxorubicin to breast cancer cells.
Tarvirdipour S; Vasheghani-Farahani E; Soleimani M; Bardania H
Int J Pharm; 2016 Mar; 501(1-2):331-41. PubMed ID: 26875475
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro and in vivo evaluations of poly(ethylene glycol)-block-poly(4-vinylbenzylphosphonate) magnetic nanoparticles containing doxorubicin as a potential targeted drug delivery system.
Hałupka-Bryl M; Asai K; Thangavel S; Bednarowicz M; Krzyminiewski R; Nagasaki Y
Colloids Surf B Biointerfaces; 2014 Jun; 118():140-7. PubMed ID: 24769390
[TBL] [Abstract][Full Text] [Related]
12. Naturally Derived Iron Oxide Nanowires from Bacteria for Magnetically Triggered Drug Release and Cancer Hyperthermia in 2D and 3D Culture Environments: Bacteria Biofilm to Potent Cancer Therapeutic.
Kumeria T; Maher S; Wang Y; Kaur G; Wang L; Erkelens M; Forward P; Lambert MF; Evdokiou A; Losic D
Biomacromolecules; 2016 Aug; 17(8):2726-36. PubMed ID: 27428076
[TBL] [Abstract][Full Text] [Related]
13. Improved cytotoxicity and preserved level of cell death induced in colon cancer cells by doxorubicin after its conjugation with iron-oxide magnetic nanoparticles.
Augustin E; Czubek B; Nowicka AM; Kowalczyk A; Stojek Z; Mazerska Z
Toxicol In Vitro; 2016 Jun; 33():45-53. PubMed ID: 26911730
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of a Folate-bovine serum albumin-doxorubicin conjugate.
Qu X; Yang C; Zhang J; Ding N; Lu Y; Huang L; Xiang G
J Drug Target; 2010 Jun; 18(5):351-61. PubMed ID: 20001219
[TBL] [Abstract][Full Text] [Related]
15. Hyperthermia with magnetic nanowires for inactivating living cells.
Choi DS; Park J; Kim S; Gracias DH; Cho MK; Kim YK; Fung A; Lee SE; Chen Y; Khanal S; Baral S; Kim JH
J Nanosci Nanotechnol; 2008 May; 8(5):2323-7. PubMed ID: 18572644
[TBL] [Abstract][Full Text] [Related]
16. Biocompatible APTES-PEG modified magnetite nanoparticles: effective carriers of antineoplastic agents to ovarian cancer.
Javid A; Ahmadian S; Saboury AA; Kalantar SM; Rezaei-Zarchi S; Shahzad S
Appl Biochem Biotechnol; 2014 May; 173(1):36-54. PubMed ID: 24615524
[TBL] [Abstract][Full Text] [Related]
17. Dual stimuli polysaccharide nanovesicles for conjugated and physically loaded doxorubicin delivery in breast cancer cells.
Pramod PS; Shah R; Jayakannan M
Nanoscale; 2015 Apr; 7(15):6636-52. PubMed ID: 25797322
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells.
Ke XY; Lin Ng VW; Gao SJ; Tong YW; Hedrick JL; Yang YY
Biomaterials; 2014 Jan; 35(3):1096-108. PubMed ID: 24183698
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Carbonyl Reductase 1 Safely Improves the Efficacy of Doxorubicin in Breast Cancer Treatment.
Jo A; Choi TG; Jo YH; Jyothi KR; Nguyen MN; Kim JH; Lim S; Shahid M; Akter S; Lee S; Lee KH; Kim W; Cho H; Lee J; Shokat KM; Yoon KS; Kang I; Ha J; Kim SS
Antioxid Redox Signal; 2017 Jan; 26(2):70-83. PubMed ID: 27357096
[TBL] [Abstract][Full Text] [Related]
20. Triple Therapy of HER2
Zolata H; Afarideh H; Davani FA
Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
